Bayer
India’s newly amended patent rules threaten affordable medicines in the Global South
New amendments to patent rules in India will jeopardize the country’s ability to produce generics, dealing a strong blow to access to medicines in both India and other countries of the Global South
Break Gilead’s patent since US has bought all stock of Remdesivir
Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far
US declares vaccine war on the world
What prevents any country from making drugs and vaccines, once developed? Is it the threat of the US, or the belief that in the US-China vaccine war, they need to be on the US side?
- Samidoun Europe coordinator targeted again by Belgian police
- Demonstrations planned across the globe on April 25 in solidarity with Gaza
- Noor Abdalla, wife of Mahmoud Khalil, gives birth while husband languishes in ICE detention
- The People’s Forum condemns right-wing attempts to silence dissent and solidarity with Palestine
- Palestine solidarity protests in Morocco delay Maersk ship
